Solas Capital Management LLC 13D and 13G filings for Fennec Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 1:00 pm Purchase |
2024-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
Solas Capital Management LLC | 2,250,919 8.200% |
327,383 (+17.02%) |
Filing |
| 2024-11-14 1:58 pm Purchase |
2024-09-30 | 13G | Fennec Pharmaceuticals Inc. FENC |
Solas Capital Management LLC | 1,923,536 7.000% |
545,023 (+39.54%) |
Filing |
| 2024-02-14 10:47 am Purchase |
2023-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
Solas Capital Management LLC | 1,378,513 5.200% |
1,378,513 (New Position) |
Filing |